Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Net Cash Flow (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Net Cash Flow for 16 consecutive years, with -$1.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Net Cash Flow rose 3.5% to -$1.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$884927.0, a 150.47% decrease, with the full-year FY2024 number at $2.5 million, up 150.96% from a year prior.
  • Net Cash Flow was -$1.2 million for Q3 2025 at Creative Medical Technology Holdings, down from -$1.2 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $13.7 million in Q2 2022 to a low of -$8.6 million in Q4 2022.
  • A 5-year average of $277763.1 and a median of -$320036.0 in 2024 define the central range for Net Cash Flow.
  • Biggest YoY gain for Net Cash Flow was 131533.57% in 2021; the steepest drop was 8817.06% in 2021.
  • Creative Medical Technology Holdings' Net Cash Flow stood at $8.3 million in 2021, then crashed by 203.63% to -$8.6 million in 2022, then soared by 87.97% to -$1.0 million in 2023, then skyrocketed by 69.23% to -$320036.0 in 2024, then crashed by 265.15% to -$1.2 million in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Net Cash Flow are -$1.2 million (Q3 2025), -$1.2 million (Q2 2025), and $1.8 million (Q1 2025).